Category
Blog
-
2023
-
FDA Approves First Gene Therapy for Specific Form of Bladder Cancer
-
AbbVie’s Vraylar Gets Expanded Approval for Major Depressive Disorder
-
FDA Expands Approval for Cytalux Imaging for Lung Cancer Detection
-
FDA Pauses IND Submission for Duchenne Therapy ENTR-601-44
-
A way to make asthma drugs last longer
-
FDA Approves Preservative-Free Latanoprost Drug for Elevated Intraocular Pressure
-
Pfizer files blockbuster hope etrasimod for ulcerative colitis
-
FDA Grants Priority Review for Enfortumab Vedotin-ejfv, Pembrolizumab for Treatment of Urothelial Cancer
-
EU Approves Atara’s Ebvallo for Posttransplant Lymphoproliferative Disease
-
FDA Approves Bispecific Antibody Mosunetuzumab-axgb to Treat Relapsed/Refractory Follicular Lymphoma